ISG15 and ovarian cancer: Our study has demonstrated that the augmented release of vesicles from ascites cells and the presence of ISG15 within these vesicles can serve as potential biomarkers for evaluating clinical prognosis in ovarian cancer (Guo et al., 2018; Kalluri & LeBleu, 2020; Liang et al., 2021).